0002031477-24-000001.txt : 20240723 0002031477-24-000001.hdr.sgml : 20240723 20240723155544 ACCESSION NUMBER: 0002031477-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240723 DATE AS OF CHANGE: 20240723 EFFECTIVENESS DATE: 20240723 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alixia, Inc. CENTRAL INDEX KEY: 0002031477 ORGANIZATION NAME: IRS NUMBER: 831896603 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-519525 FILM NUMBER: 241134426 BUSINESS ADDRESS: STREET 1: 953 INDIANA STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 BUSINESS PHONE: 858-922-9965 MAIL ADDRESS: STREET 1: 953 INDIANA STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 D 1 primary_doc.xml X0708 D LIVE 0002031477 Alixia, Inc. 953 INDIANA STREET SAN FRANCISCO CA CALIFORNIA 94107 858-922-9965 DELAWARE Guided Clarity, Inc. None Corporation true 2022 Helen Yee-Fang Chen 953 Indiana Street San Francisco CA CALIFORNIA 94107 Executive Officer Director Lars Olof Mollstedt 953 Indiana Street San Francisco CA CALIFORNIA 94107 Executive Officer Director Sungwon Lim 953 Indiana Street San Francisco CA CALIFORNIA 94107 Director Biotechnology Decline to Disclose 06b false 2024-07-09 false true false 0 3465450 1825445 1640005 The Total Amount Sold includes the conversion of Simple Agreements for Future Equity and Accelerator Contracts for Equity with an aggregate purchase price of $1,465,450. false 19 0 0 0 false Alixia, Inc. /s/Helen Yee-Fang Chen Helen Yee-Fang Chen Co-Chief Executive Officer 2024-07-23